Henry Schein (NASDAQ:HSIC) Given New $78.00 Price Target at Evercore ISI

Henry Schein (NASDAQ:HSIC - Get Free Report) had its target price lifted by stock analysts at Evercore ISI from $72.00 to $78.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has an "in-line" rating on the stock. Evercore ISI's target price points to a potential upside of 6.24% from the company's current price.

A number of other brokerages have also weighed in on HSIC. Wells Fargo & Company reduced their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Barrington Research dropped their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Piper Sandler dropped their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Finally, Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Henry Schein has an average rating of "Moderate Buy" and a consensus target price of $79.70.

Henry Schein Stock Down 1.5%

Shares of HSIC traded down $1.11 during midday trading on Wednesday, reaching $73.42. The stock had a trading volume of 1,446,652 shares, compared to its average volume of 1,727,684. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49. The company's fifty day simple moving average is $71.56 and its two-hundred day simple moving average is $71.33. The company has a market cap of $8.94 billion, a price-to-earnings ratio of 22.94, a PEG ratio of 2.37 and a beta of 0.87. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the business earned $1.10 EPS. The company's revenue was down .1% on a year-over-year basis. Equities research analysts expect that Henry Schein will post 4.74 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of HSIC. Palestra Capital Management LLC purchased a new position in Henry Schein during the 4th quarter worth $182,988,000. Lyrical Asset Management LP purchased a new position in Henry Schein during the 4th quarter worth $126,655,000. Norges Bank purchased a new position in Henry Schein during the 4th quarter worth $103,301,000. Steadfast Capital Management LP lifted its stake in shares of Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock worth $113,336,000 after acquiring an additional 1,175,408 shares during the period. Finally, Hudson Bay Capital Management LP lifted its stake in shares of Henry Schein by 102.1% in the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company's stock worth $101,378,000 after acquiring an additional 740,007 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.